Organogenesis Holdings, Inc. Class A
(NASDAQ: ORGO)

Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

4.965

+0.045 (+0.91%)
Range 4.900 - 4.970   (1.43%)
Open 4.940
Previous Close 4.920
Bid Price 3.670
Bid Volume 11
Ask Price 3.450
Ask Volume 18
Volume 44,712
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis